Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
about
Protein kinase cascades in the regulation of cardiac hypertrophyRemodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis.The mTOR-FAK mechanotransduction signaling axis for focal adhesion maturation and cell proliferation.Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivoInfluence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheepA cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1.3,3'-Diindolylmethane protects against cardiac hypertrophy via 5'-adenosine monophosphate-activated protein kinase-α2Capacity for resolution of Ras-MAPK-initiated early pathogenic myocardial hypertrophy modeled in mice.Rheb is essential for murine developmentPik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathwayTargeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy.Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in miceHypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling.IRAK4 deficiency promotes cardiac remodeling induced by pressure overload.New concepts of endoplasmic reticulum function in the heart: programmed to conserve.Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy.Prolonged exposure to GH impairs insulin signaling in the heart.Insulin signalling in the heart.Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipientsTranslation inhibition reveals interaction of 2'-deoxy and 2'-O-methyl molecular beacons with mRNA targets in living cells.Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice.Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.Cardioprotective signaling by endothelinInteractions between the regulatory subunit of type I protein kinase A and p90 ribosomal S6 kinase1 regulate cardiomyocyte apoptosis.Mammalian target of rapamycin signaling in cardiac physiology and disease.Erbin is a negative modulator of cardiac hypertrophy.New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.Systems biological approaches to the cardiac signaling network.Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.MicroRNAs in a hypertrophic heart: from foetal life to adulthood.Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failureUremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD).
P2860
Q24518494-794B03EE-FF5C-4110-A42D-81242BE98611Q26853332-FE45201B-9DBC-4CE2-9273-B0B7A8E6971CQ28585415-F31A8796-131B-4CC5-818D-1D4DDA745E97Q30357240-0A3FF004-94FA-4C7C-A951-E8F5C44CAFA2Q33807091-F9D25D3E-2DF1-44A8-B016-CFF554472D3DQ33954489-C13C35D9-A09D-4A8C-BE2D-D4A9AAD2CF96Q33983596-455FFF64-EE14-4714-9195-40FFCF08B27BQ34035845-EC43FBF5-B991-4502-BABB-293B36CCE9DBQ34273479-0D80D087-A83A-4B30-85E5-20F71BDB4E8CQ34551381-0E97031F-7163-48BF-B3F9-127F61F39E6DQ34819898-287E85DA-A42F-45EA-8F9B-97930C54AD79Q35077120-2D4190F9-A39A-4E3B-8FB7-5DA8006D7DF7Q35235090-82ECF272-48F2-4295-863D-DE05C2F273C7Q35674329-5077806C-6E73-4DD8-A4E5-0911709E0709Q35677930-93D57BC3-BCAB-4068-9899-474A161AB0B2Q35840605-2A7CCB82-E1F8-4E98-BF7D-976EFC24DED0Q36492742-71B1EE02-AD2C-4491-AA59-278130A10B4AQ36570092-FFB0B8E6-6587-4879-9BE1-A190B6295B48Q36681254-86C2CCA8-711C-44EF-8EA6-958A93469546Q36682368-EC8AFFC5-CBF3-45B4-8B39-E3E184DE06D8Q36909237-6B876384-10A2-4491-987D-9CD650150AD9Q37102358-7CAA805F-FA79-49B7-A85A-6E60F590426DQ37129268-BAFD470E-6905-4A0A-A080-9BB53415A6A8Q37291483-EC40AACD-E63C-4B47-9A5F-1D17E4E4813EQ37318474-8156D0F9-E138-4702-922D-586C5D91DF20Q37328511-D2AD2ACB-332A-4321-A55B-66220E40AB7EQ37353815-9314FC10-0AD0-4997-9DDB-33C3CC4F0AD0Q37397982-9E2219CF-006B-4E85-A7B0-931F198E6320Q37553501-92C1C014-6BB1-47D8-B7EC-E24AFC816586Q37715817-0160D695-7D37-4ABB-96A2-7EC07BB95482Q37725186-A84CFE9F-CFDF-430E-9819-3A67CB0D44BDQ37776431-9F91EE62-A246-4A0F-9CEB-06EE603811AFQ38190099-9948E3F0-E08F-4DE0-A08D-AF86F556B9ACQ38537087-AAF0134D-36E8-41A6-9247-9F1D80C65549Q39247355-8E32D64E-CAE3-4795-A265-E1784036ED41Q39256900-01134E32-52B8-4D16-BF9F-3E3456532047Q39720055-B96DCBA0-68D5-4930-9A26-4B179785CFABQ41866389-CDACFC2A-BCF0-404D-A75B-C3074DF45095Q41980949-B103B360-1A48-40E4-AC29-7B4B63466E7BQ43069328-3FF02D75-E691-43B5-AA78-46FAC6E6D099
P2860
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
@ast
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
@en
type
label
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
@ast
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
@en
prefLabel
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
@ast
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
@en
P1476
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
@en
P304
P356
10.1016/J.CARDIORES.2004.02.003
P577
2004-08-01T00:00:00Z